netFormulary
 Report : A-Z NHS England items in Formulary 15/06/2024 18:05:12
[Back]
 
Section Status NHS England Name
08.01.05 Formulary MHS England Acalabrutinib Calquence®
08.01.05 Formulary MHS England Afatinib  
08.01.05 Formulary MHS England Alectinib Alecensa®
08.02.03 Formulary MHS England Alemtuzumab 
08.03.04.01 Formulary MHS England Alpelisib Piqray®
08.01.05 Formulary MHS England Asciminib Scemblix®
09.08.01 Formulary MHS England Asfotase alfa Strensiq®
08.01.05 Formulary MHS England Atezolizumab 
09.08.01 Formulary MHS England Avalglucosidase alfa Nexviadyme®
08.02.03 Formulary MHS England Avelumab Bavencio®
08.01.05 Formulary MHS England Axicabtagene ciloleucel 
08.01.05 Formulary MHS England Axitinib  Inlyta®
03.04.02 Formulary MHS England Benralizumab Fasenra®
08.01.05 Formulary MHS England Bortezomib  
08.01.05 Formulary MHS England Bosutinib Bosulif®
08.01.05 Formulary MHS England Brexucabtagene autoleucel Tecartus®
08.01.05 Formulary MHS England Brigatinib Alunbrig®
05.03.03.02 Formulary MHS England Bulevirtide Hepcludex®
03.04.03 Formulary MHS England C1 Esterase Inhibitor 
08.01.05 Formulary MHS England Cabozantinib Cometriq®
04.06 Formulary MHS England Cannabidiol  Epidyolex®
04.08.01 Formulary MHS England Cannabidiol Epidyolex®
08.01.05 Formulary MHS England Carfilzomib Kyprolis®
08.01.05 Formulary MHS England Cemiplimab Libtayo®
08.01.05 Formulary MHS England Ceritinib  
08.01.05 Formulary MHS England Chlormethine Gel 
08.01.05 Formulary MHS England Dabrafenib  Tafinlar®
05.03.03.02 Formulary MHS England Daclatasvir  
08.01.05 Formulary MHS England Dacomitinib Vizimpro®
08.01.05 Formulary MHS England Daratumumab Darzalex®
08.03.04.02 Formulary MHS England Darolutamide Nubeqa®
08.01.03 Formulary MHS England Daunorubicin/cytarabine Vyxeos®
13.14.07 Formulary MHS England Difelikefalin Kapruvia®
08.02.04 Formulary MHS England Dimethyl fumarate Tecfidera®
08.01.05 Formulary MHS England Dinutuximab beta Qarziba®
08.02.04 Formulary MHS England Diroximel fumarate Vumerity®
05.03.01 Formulary MHS England Dolutegravir Sodium & Lamivudine Dovato®
05.03.01 Formulary MHS England Dolutegravir Sodium & Rilpivirine Hydrochloride Juluca®
08.01.05 Formulary MHS England Dostarlimab  Jemperli
03.04.02 Formulary MHS England Dupilumab Dupixent®
13.05.03 Formulary MHS England Dupilumab Dupixent®
08.01.05 Formulary MHS England Durvalumab Imfinzi®
05.03.03.02 Formulary MHS England Elbasvir & grazoprevir Zepatier®
05.03.01 Formulary MHS England Emtricitabine & Elvitegravir & Cobicistat & Tenofovir alafenamide Genvoya®
05.03.01 Formulary MHS England Emtricitabine & Rilpivirine & Tenofovir alafenamide Odefsey®
05.03.01 Formulary MHS England Emtricitabine & Rilpivirine & Tenofovir disoproxil Eviplera®
05.03.01 Formulary MHS England Emtricitabine & Tenofovir alafenamide Descovy®
05.03.01 Formulary MHS England Emtricitabine & Tenofovir Disoproxil 
08.01.05 Formulary MHS England Encorafenib Braftovi®
08.01.05 Formulary MHS England Entrectinib Rozlytrek®
08.01.05 Formulary MHS England Eribulin Halaven®
04.08.01 Formulary MHS England Fenfluramine Fintepla®
08.02.04 Formulary MHS England Fingolimod 
04.09.01 Formulary MHS England Foslevidopa/foscarbidopa  Produodopa®
05.03.01 Formulary MHS England Fostemsavir Rukobia®
08.01.05 Formulary MHS England Gemtuzumab ozogamicin Mylotarg®
08.01.05 Formulary MHS England Gilteritinib Xospata®
08.02.04 Formulary MHS England Glatiramer Acetate 
05.03.03.02 Formulary MHS England Glecaprevir & Pibrentasvir Maviret®
08.01.05 Formulary MHS England Glofitamab Columvi®
08.01.05 Formulary MHS England Ibrutinib Imbruvica®
03.04.03 Formulary MHS England Icatibant Firazyr®
08.01.05 Formulary MHS England Idelalisib  
08.01.05 Formulary MHS England Imatinib  
08.01.05 Formulary MHS England Imlifidase Idefirix®
04.12 Formulary MHS England Inotersen  Tegsedi®
08.01.05 Formulary MHS England Inotuzumab ozogamicin Besponsa®
08.02.04 Formulary MHS England Interferon Beta Avonex®
08.02.04 Formulary MHS England Interferon Beta Rebif®
08.02.04 Formulary MHS England Interferon Beta Betaferon®
08.02.04 Formulary MHS England Interferon beta Extavia®
08.01.05 Formulary MHS England Ipilimumab Yervoy®
08.01.05 Formulary MHS England Ivosidenib Tibsovo®
03.04.03 Formulary MHS England Lanadelumab Takhzyro®
08.01.05 Formulary MHS England Larotrectinib 
08.02.04 Formulary MHS England Lenalidomide 
08.01.05 Formulary MHS England Lenvatinib Kisplyx®
05.03.02.02 Formulary MHS England Letermovir Prevymis®
04.09.01 Formulary MHS England Levidopa/carbidopa Intestinal Gel Duodopa®
08.01.05 Formulary MHS England Loncastuximab tesirine Zynlonta®
08.01.05 Formulary MHS England Lorlatinib Lorviqua®
03.07 Formulary MHS England Lumacaftor and Ivacaftor Orkambi®
05.03.02.02 Formulary MHS England Maribavir Livtencity®
03.04.02 Formulary MHS England Mepolizumab Nucala®
06.08 Formulary MHS England Metreleptin 
08.01.05 Formulary MHS England Midostaurin Rydapt®
08.01.05 Formulary MHS England Mobocertinib 
08.01.05 Formulary MHS England Mogamulizumab  Poteligeo®
08.02.04 Formulary MHS England Natalizumab 
08.01.05 Formulary MHS England Neratinib Nerlynx®
08.01.05 Formulary MHS England Nilotinib Tasigna®
08.01.05 Formulary MHS England Niraparib Zejula®
08.01.05 Formulary MHS England Nivolumab  Opdivo®
08.02.03 Formulary MHS England Obinutuzumab 
08.02.03 Formulary MHS England Ocrelizumab Ocrevus®
08.02.03 Formulary MHS England Ofatumumab  Kesimpta®
08.01.05 Formulary MHS England Olaparib  Lynparza®
03.04.02 Formulary MHS England Omalizumab Xolair®
08.03.04.01 Formulary MHS England Palbociclib Ibrance®
05.03.05 Formulary MHS England Palivizumab 
08.01.05 Formulary MHS England Panobinostat  
04.12 Formulary MHS England Patisiran Onpattro®
08.02.04 Formulary MHS England Peginterferon Beta-1a Plegridy®
08.01.05 Formulary MHS England Pembrolizumab  Keytruda®
08.01.05 Formulary MHS England Pertuzumab Perjeta®
08.01.05 Formulary MHS England Polatuzumab vedotin Polivy®
08.02.04 Formulary MHS England Ponesimod Ponvory®
03.04.02 Formulary MHS England Reslizumab Cinquil®
05.03.03.02 Formulary MHS England Ribavirin 
08.03.04.01 Formulary MHS England Ribociclib Kisqali®
01.05.03 Formulary MHS England Risankizumab Skyrizi®
08.01.05 Formulary MHS England Sacituzumab govitecan Trodelvy®
09.08.01 Formulary MHS England Sebelipase Kanuma®
08.01.05 Formulary MHS England Selumetinib Koselugo®
06.07 Formulary MHS England Setmelanotide Imcivree®
08.02.04 Formulary MHS England Siponimod Mayzent®
05.03.03.02 Formulary MHS England Sofosbuvir Sovaldi®
05.03.03.02 Formulary MHS England Sofosbuvir & Ledipasvir  Harvoni®
05.03.03.02 Formulary MHS England Sofosbuvir & velpatasvir  Epclusa®
05.03.03.02 Formulary MHS England Sofosbuvir, Velpatasvir & Voxilaprevir  Vosevi®
08.01.05 Formulary MHS England Sunitinib  Sutent®
08.01.05 Formulary MHS England Talimogene laherparepvec 
01.04.02 Formulary MHS England Teduglutide Revestive®
08.02 Formulary MHS England Tepotinib Tepmetko®
08.02.04 Formulary MHS England Teriflunomide 
03.07 Formulary MHS England Tezacaftor and ivacaftor  Symkevi®
03.07 Formulary MHS England Tezacaftor with ivacaftor and elexacaftor Kaftrio®
03.04.02 Formulary MHS England Tezepelumab Tezspire®
08.01.05 Formulary MHS England Tisagenlecleucel 
10.01.03 Formulary MHS England Tocilizumab RoActemra®
08.01.05 Formulary MHS England Trametinib  
08.01.05 Formulary MHS England Trastuzumab deruxtecan Enhertu
08.01.05 Formulary MHS England Tucatinib Tukysa®
09.08.01 Formulary MHS England Velmanase alfa Lamzede ®
08.01.05 Formulary MHS England Venetoclax Venclyxto®
08.02.02 Formulary MHS England Voclosporin  Lupkynis®
19 Formulary MHS England Volanesorsen  Waylivra®
04.12 Formulary MHS England Vutrisiran Amvuttra®
08.01.05 Formulary MHS England Zanabrutinib Brukinsa
08.01.05 Formulary MHS England Zanubrutinib Brukinsa 80mg capsules®
North East and North Cumbria